In this context, it should be noted that although 11-HSD1 is essential for intracellular regeneration of GCs, 11-HSD1 deficiency or inhibition is associated with increased adrenal production of GCs to maintain normal circulating levels27,28. infected with AS. In contrast, 11-HSD1 deficiency rather decreased parasitemia in mice infected with the reticulocyte-restricted GSK1324726A (I-BET726) parasite NK65 1556Cl1. Malaria-induced antibody production and pathology were unaltered by 11-HSD1 deficiency though plasma levels of IL-4, IL-6 and TNF- were slightly affected by 11-HSD1 deficiency, dependent on the infecting parasite. These data suggest that 11-HSD1 is not crucial for survival of experimental malaria, but alters its progression in a parasite strain-specific manner. Introduction Malaria is a global health problem with an estimated 200 million clinical cases and 438,000 deaths in 20151. Usually, malaria manifests as a mild febrile disease but complications can arise and include cerebral malaria (CM), severe malarial anaemia, placental malaria, hypoglycaemia and malaria-associated acute respiratory distress syndrome (MA-ARDS). Current antimalarial drugs effectively inhibit GSK1324726A (I-BET726) parasite growth but cannot resolve malaria complications, resulting in a mortality of about 15% for CM and up to 80% for MA-ARDS2C4. The immune response to malaria needs to be well balanced in order to control the infection without causing an overwhelming inflammation5C7. Inflammatory processes are thought to contribute significantly to the pathogenesis of specific malaria complications. For example, MA-ARDS is characterized by alveolar inflammation with infiltrating monocytes, macrophages, lymphocytes and neutrophils3. Anti-inflammatory molecules are essential to prevent immunopathology and include interleukin-10 (IL-10), transforming growth factor- (TGF-), heme oxygenase 1 (HO-1) and cytotoxic T-lymphocyteCassociated antigen 4 (CTLA-4)8C13. In previous studies, an increase in blood cortisol levels was reported in or parasites: AS (NK65 (and in which exon 3 is flanked by sites39 with mice expressing recombinase under the control of the promoter, expressed in the germ line40. To generate non-transgenic littermates as wild-type (WT) controls, C57Bl/6 mice were mated with mice to yield F1 heterozygotes. The latter were inter-crossed to obtain mice and matched WT controls in Rabbit polyclonal to ZNF76.ZNF76, also known as ZNF523 or Zfp523, is a transcriptional repressor expressed in the testis. Itis the human homolog of the Xenopus Staf protein (selenocysteine tRNA genetranscription-activating factor) known to regulate the genes encoding small nuclear RNA andselenocysteine tRNA. ZNF76 localizes to the nucleus and exerts an inhibitory function onp53-mediated transactivation. ZNF76 specifically targets TFIID (TATA-binding protein). Theinteraction with TFIID occurs through both its N and C termini. The transcriptional repressionactivity of ZNF76 is predominantly regulated by lysine modifications, acetylation and sumoylation.ZNF76 is sumoylated by PIAS 1 and is acetylated by p300. Acetylation leads to the loss ofsumoylation and a weakened TFIID interaction. ZNF76 can be deacetylated by HDAC1. In additionto lysine modifications, ZNF76 activity is also controlled by splice variants. Two isoforms exist dueto alternative splicing. These isoforms vary in their ability to interact with TFIID the F2 generation. Overall, mice were backcrossed to C57Bl/6 mice for more than 6 generations. Strain background strongly influences the course of malarial infection in mice. To characterize the percentage of C57Bl/6 background of WT and mice, background strain characterization was performed on genomic tail DNA from 3 mice and 3 of their WT littermates (Taconic, Rensselaer, NY, USA). A panel of 1449 SNP markers, covering all chromosomes, was compared to a C57Bl/6?J reference strain. This confirmed that mice showed 99.93C100% similarity to the C57Bl/6 reference genome. The characterization of all SNPs can be found as Supplementary Table?S1. Infection of mice and clinical scoring As described previously41, mice were housed in a conventional animal house and intraperitoneally injected with 104 RBCs infected with and drinking water was supplemented with para-amino benzoic acid (PABA; Sigma-Aldrich, Bornem, Belgium) to facilitate parasite growth. Body weight, parasitemia, and clinical parameters including spontaneous activity (SA), limb grasping (LG), body tone (BT), trunk curl (TC), pilo-erection (PE), shivering (Sh), abnormal breathing (AB), dehydration (D), incontinence (I) and paralysis (P) were evaluated daily to calculate a clinical score of disease severity. A disease score was given of 0 (absent) or 1 (present) for TC, PE, Sh and AB and 0 (normal), 1 (intermediate) or 2 (most serious) for the other parameters. The total clinical score was calculated by the following formula: SA?+?LG?+?BT?+?TC?+?PE?+?Sh?+?AB?+?3*(D?+?I?+?P). Peripheral parasitemia (percentage of RBCs that are infected) was determined by microscopic analysis of blood smears after Giemsa staining (VWR, Leuven, Belgium). Mice were euthanized when the humane endpoints were reached (clinical score of 15 or more) or at the indicated time points. Collection of tissues Upon euthanasia, blood was collected by heart puncture. The left lung was pinched off and bronchoalveolar lavage GSK1324726A (I-BET726) fluid (BALF) was collected from the right lung as described previously41. Mice were systemically perfused (transcardial route) with PBS to remove circulating blood. Organs were removed, weighed and stored at ?80?C. Determination of glucose, protein and cytokine levels and assessment of liver pathology Blood samples were centrifuged and plasma glucose concentrations were measured in duplicate.